Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score50
United States Fiscal year ends December CIK 0001501989 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Christopher Ogden
15 Jun 2026
Chief Financial Officer
Sell
1,624
$3.05
$4.95K
Christopher Ogden
17 Mar 2026
Chief Financial Officer
Sell
19,323
$6.42
$124.11K
Marcia Belvin
17 Mar 2026
SVP, Chief Scientific Officer
Sell
31,492
$6.42
$202.27K
Sean A. McCarthy
17 Mar 2026
CEO
Sold on a plan
118,969
$6.42
$764.14K
Yu-Waye Chu
17 Mar 2026
Chief Medical Officer
Sell
21,279
$6.42
$136.68K
Sean A. McCarthy
6 Nov 2025
CEO
Sold on a plan
101,793
$4.54
$461.91K

What was left out

Form 4 filings counted 20
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 555,000
History held since 9 Oct 2015